COO
Price
$53.91
Change
-$0.26 (-0.48%)
Updated
Sep 11 closing price
Capitalization
10.25B
82 days until earnings call
Intraday BUY SELL Signals
OM
Price
$3.21
Change
-$0.06 (-1.83%)
Updated
Sep 11 closing price
Capitalization
60.34M
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COO vs OM

COO vs OM Comparison Chart in %
View a ticker or compare two or three
VS
COO vs. OM commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a Buy and OM is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COO($10.2B) has a higher market cap than OM($60.3M). OM YTD gains are higher at: -13.477 vs. COO (-34.224). COO has higher annual earnings (EBITDA): 890M vs. OM (-56.31M). OM has more cash in the bank: 147M vs. COO (139M). OM has less debt than COO: OM (104M) vs COO (2.46B). COO has higher revenues than OM: COO (4.23B) vs OM (118M).
COOOMCOO / OM
Capitalization10.2B60.3M16,915%
EBITDA890M-56.31M-1,580%
Gain YTD-34.224-13.477254%
P/E Ratio18.52N/A-
Revenue4.23B118M3,586%
Total Cash139M147M95%
Total Debt2.46B104M2,365%
FUNDAMENTALS RATINGS
COO vs OM: Fundamental Ratings
COO
OM
OUTLOOK RATING
1..100
5057
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8898
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
89100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OM's Valuation (18) in the null industry is somewhat better than the same rating for COO (58) in the Medical Specialties industry. This means that OM’s stock grew somewhat faster than COO’s over the last 12 months.

OM's Profit vs Risk Rating (100) in the null industry is in the same range as COO (100) in the Medical Specialties industry. This means that OM’s stock grew similarly to COO’s over the last 12 months.

COO's SMR Rating (88) in the Medical Specialties industry is in the same range as OM (98) in the null industry. This means that COO’s stock grew similarly to OM’s over the last 12 months.

COO's Price Growth Rating (65) in the Medical Specialties industry is in the same range as OM (65) in the null industry. This means that COO’s stock grew similarly to OM’s over the last 12 months.

COO's P/E Growth Rating (89) in the Medical Specialties industry is in the same range as OM (100) in the null industry. This means that COO’s stock grew similarly to OM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COOOM
RSI
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
56%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (COO: $53.91 vs. OM: $3.21)
Brand notoriety: COO and OM are both not notable
COO represents the Pharmaceuticals: Other, while OM is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: COO: 268% vs. OM: 68%
Market capitalization -- COO: $10.25B vs. OM: $60.34M
COO [@Pharmaceuticals: Other] is valued at $10.25B. OM’s [@Medical/Nursing Services] market capitalization is $60.34M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green while OM’s FA Score has 1 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • OM’s FA Score: 1 green, 4 red.
According to our system of comparison, OM is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 5 TA indicator(s) are bullish while OM’s TA Score has 4 bullish TA indicator(s).

  • COO’s TA Score: 5 bullish, 5 bearish.
  • OM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, COO is a better buy in the short-term than OM.

Price Growth

COO (@Pharmaceuticals: Other) experienced а -22.53% price change this week, while OM (@Medical/Nursing Services) price change was -10.58% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

Reported Earning Dates

COO is expected to report earnings on Dec 03, 2026.

OM is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
COO
Daily Signal:
Gain/Loss:
OM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRMM4.570.04
+0.88%
Forum Markets Incorporated
CLBR10.230.01
+0.10%
Colombier Acquisition Corp. III
NBRGU10.23N/A
N/A
Newbridge Acquisition Ltd
FROG87.18-1.47
-1.66%
JFrog Ltd
VIA25.76-0.60
-2.28%
Via Transportation Inc.

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with BDX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then BDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
-0.48%
BDX - COO
56%
Loosely correlated
+0.81%
A - COO
50%
Loosely correlated
+2.66%
ICUI - COO
47%
Loosely correlated
-0.50%
DHR - COO
46%
Loosely correlated
-0.19%
SYK - COO
44%
Loosely correlated
+2.06%
More

OM and

Correlation & Price change

A.I.dvisor indicates that over the last year, OM has been loosely correlated with COO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OM jumps, then COO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OM
1D Price
Change %
OM100%
-1.83%
COO - OM
34%
Loosely correlated
-0.48%
CVRX - OM
33%
Loosely correlated
+0.70%
RMD - OM
33%
Loosely correlated
-0.60%
GH - OM
32%
Poorly correlated
-1.04%
BDX - OM
31%
Poorly correlated
+0.81%
More